Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 106.11 K298.05 K128.08 K — Research & development ——— — Operating income -106.11 K-298.05 K-128.08 K — Non-Operating Income, Total 187.42 K—— — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 187.42 K—— — Unusual income/expense ——— — Pretax income 81.31 K-298.05 K-128.08 K — Equity in earnings ——— — Taxes ——— — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 81.56 K2.38 M2.35 M — Discontinued operations ——— — Net income 81.56 K2.38 M2.35 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 81.56 K2.38 M2.35 M — Basic earnings per share (Basic EPS) 0.040.320.64 — Diluted earnings per share (Diluted EPS) 0.040.320.6 — Average basic shares outstanding 14.18 M30.71 M38.91 M — Diluted shares outstanding 14.18 M31.74 M39.68 M — EBITDA ——— — EBIT -105.86 K-291.59 K-120.6 K — Cost of revenue ——— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) ——— —